Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients ; volume:21 ; number:1 ; day:9 ; month:11 ; year:2023 ; pages:1-9 ; date:12.2023
Cost effectiveness and resource allocation ; 21, Heft 1 (9.11.2023), 1-9, 12.2023
- Creator
-
Suthutvoravut, Unyaporn
Kunakorntham, Patratorn
Semayai, Anchisatha
Tansawet, Amarit
Oraluck Pattanaprateep
Piebpien, Pongsathorn
Numthavaj, Pawin
Thakkinstian, Ammarin
Atiksawedparit, Pongsakorn
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12962-023-00497-x
- URN
-
urn:nbn:de:101:1-2024012911263028775410
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Suthutvoravut, Unyaporn
- Kunakorntham, Patratorn
- Semayai, Anchisatha
- Tansawet, Amarit
- Oraluck Pattanaprateep
- Piebpien, Pongsathorn
- Numthavaj, Pawin
- Thakkinstian, Ammarin
- Atiksawedparit, Pongsakorn
- SpringerLink (Online service)
Other Objects (12)
Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer
Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer
Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making